(±)-Trans-2-[3-methoxy-4-(4-chlorophenyl thioethoxy)-5-cyanophenyl]-5- (3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent PAF-receptor antagonist

Tetrahedron

Volumn 55, Issue 33, 1999, Pages 10163-10172

  Ram, B ^a   Balram, B ^a   Sai Prakash, P K ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

2,5 transdiaryltetrahydrofuran; Acetovanillone; Platelet activating factor

Indexed keywords

2 [3 METHOXY 4 (4 CHLOROPHENYLTHIOETHOXY) 5 CYANOPHENYL] 5 (3,4,5 TRIMETHOXYPHENYL)TETRAHYDROFURAN; APOCYNIN; BENZALDEHYDE DERIVATIVE; TETRAHYDROFURAN DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; DIASTEREOISOMER; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0033551729     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(99)00544-X     Document Type: Article

References (16)

1. Braquet, P.; Tougui, L.; Shen, T.Y.; Vargaftig, B.B. Pharmacol. Rev. 1987, 39, 97.
2. Godfroid, J.J.; Heymans, F.; Michel, E.; Redeuilh, C.; Steiner, E.; Benveniste, J. FEBS Lett., 1980, 116, 161.
3. Benveniste, J.; Henson, P.M.; Cochrane, C.G. J. Exp. Med. 1972, 136, 1356.
4. Hwang, S.B.; Lam, M.H.; Biftu, T.; Beattie, T.R.; Shon, T.Y. J. Biol. Chem. 1985, 260, 15639.
5. Biftu, T.; Bamble, NF.; Doebber, T.; Hwang, S.B.; Shon, T.Y.; Snyder, J.; Springer, J.P.; Stevenson, R. J. Med Chem. 1986, 29, 1917.
6. Hwang, S.B.; Lam, M.H.; Alberts, A.W.; Bugianesi, R.L.; Chabala, J.C.; Ponpipom, M.M. J. Pharmacol. Exp. Ther., 1988, 246, 534.
7. a) Ponpipom, M.M.; Hwang, S.B.; Doebber, T.W.; Acton, J.J.; Alberts, A.W.; Biftu, T.; Brooker, D.R.; Buggianesi, R.L.; Chabala, J.C.; Gamble, N.L.; Braham, D.W.; Lam, M.H.; Wu, M.S. Biochem. Biophys. Res. Commun. 1988, 150, 1213.
8. b) Biftu, T.; Chabala, J.C.; Acton, J.J. Kuo, C.H. Drugs Future, 1989, 14, 359.
9. a) For the first synthesis of the 2S,5S enantiomer of L-659, 989 see: Ponpipom, M.M.; Bugianesi, R.L.; Chabala, J.C. Tetrahedron Lett., 1988, 29, 6211.
10. b) For an enantioselective synthesis using iodide 1 as well as silyl acetyl activation, see: Thompson, A.S.; Tschaen, D.M.; Simpson, P.; McSwine, D.J.; Russ, W.; Little, E.D.; Verhoeven, T.R.; Shinkai, I. Tetrahedron Lett., 1990, 31, 6953.
11. Xiong, Cai.; Ralph Scanell, J.; David Yaeger.; David Killian, B. J. Med. Chem., 1998, 41, 1970.
12. Hussion, M.S.; Cai, X.; Scanell, R.; Yaeger, D.; Killian, D.B.; Eckman, J.; Hwang, S.; Grahan, L.L.; Quian, C.; Yeh, G.; Ip, S. CMI-206 : A potent dual platellet activating factor antagonist and 5-lipoxygenase inhibitor. Biorg. Med. Chem. Lett., 1995, 5, 643-8.
13. Girotra, N.N.; Biftu, J.; Ponpipom, M.M.; Acton, J.J.; Alberts, A.W.; Bach, T.N.; Ball, R.G. J. Med Chem. 1992, 35, 3474-3482.
14. Thompson, A.S.; Jschaen, D.M.; Simpson, P.; Mcswine, D.J.; Reamer, R.A.; Verhoeven, T.R.; Shinkai, I.J. J. Org. Chem. 1992, 57, 7044.
15. Sahoo, S.P.; Graham, D.W.; Acton, J.J.; Biftu, J.; Bugianeasi, R.L.; Girotra, N.N.; Ponpipm, M.M. Bioorg. Med. Chem. Lett., 1991, 1, 327.
16. Ponpipom, M.M.; Hwang, S.B.; Doebber, T.W.; Acton, J.J. Biochem and Biophys. Res. Comm., 1988, 41, 1970.